Pharmaceutical Industry Articles & Reports - Page 27

Learn the SCDC framework for differentiated messaging of high-value AI solutions in life sciences. This guide explains how to tailor content for diverse stakeho

Explore a 2026 ROI analysis of Quality 4.0 in pharma manufacturing. Learn how technologies like AI & digital twins drive up to 45% cost savings and 40% capacity

Learn what a Case Report Form (CRF) library is and how it improves clinical trials. Covers CDASHIG v2.1, ODM-XML v2.0, Veeva Vault EDC, Medidata Designer AI, and the FDA Dataset-JSON RFC (Apr 2025).

Explore OpenStudyBuilder, the open-source platform for clinical study specifications. Updated for 2026 with ICH M11 adoption, CDISC 360i launch, USDM 4.0, and growing multi-company collaboration.

Updated April 2026 for ServiceNow's Yokohama and Zurich releases, the Moveworks acquisition, and new FDA/EMA AI guidance. A guide to ServiceNow use cases in healthcare and life sciences – ITSM for clinical workflows, patient experience, HIPAA/GxP compliance, EMR integration, and agentic AI.

An in-depth analysis of OpenAI's GPT-5.2 breakthrough on ARC-AGI-2 (54% in Dec 2025), the rapid progress to 98% by April 2026, and the launch of ARC-AGI-3 that humbled all frontier models back to near-zero.

Explore the modern biotech lab's evolution in 2026. Learn how automation, AI, self-driving labs, and digital tools are transforming research, from high-throughput screening to autonomous discovery platforms.

An analysis of the Agentic AI Foundation (AAIF) by the Linux Foundation. Updated April 2026 with 170+ members, MCP's 110M+ monthly downloads, A2A v1.0, and enterprise adoption stats.

Explore document automation for pharma in 2026. Learn how template-driven assembly, structured content, and agentic AI can cut CSR authoring time by 40-90%, with real-world case studies from Merck, Narrativa, and more

Learn how Retrieval-Augmented Generation (RAG) connects ELN, LIMS, and institutional knowledge for drug discovery. Updated for 2026 with FDA/EMA AI guidelines, Benchling AI agents, GraphRAG, and latest market data.

Learn how machine learning (ML) and AI are transforming pharmaceutical CMC process optimization in 2026. Covers applications, digital twins, regulatory updates (FDA/EMA 2026 AI principles, FRAME initiative), and real-world case studies.

Learn how generative AI and LLMs assist in drafting pharma IND & CTA submissions. This guide covers benefits, risks, GxP compliance, FDA/EMA 2026 joint AI principles, and tools like AutoIND and Narrativa.

Learn to build an AI-powered competitive intelligence stack for biotech in 2026. Covers data sources, NLP/ML methods, generative AI, agentic workflows, EU AI Act compliance, and use cases for R&D strategy.

An educational guide to making your biotech AI-ready. Explore essential data infrastructure fixes for data quality, integration, compute, and governance — updated for 2026 with the latest on pharma supercomputers, FDA/EMA AI guidance, and industry best practices.

An analysis of the 2025 RAM shortage. Learn how massive AI demand for HBM is straining the DRAM supply, leading to surging prices for PC, gaming, and server mem

NVIDIA H100: $25K-$40K. H200: ~$31K ($315K/8-GPU). B200: $30K-$50K. B300: $300K-$350K. Full 2026 buy vs. cloud rental cost breakdown.

Updated April 2026 guide to Microsoft Copilot pricing ($30/user add-on, $99 E7 Frontier Suite), licensing changes, April 2026 paywall updates, and qualifying Microsoft 365 plans.

An in-depth guide to Mistral Large 3, the open-source MoE LLM. Learn about its architecture, 675B parameters, 256k context window, benchmark performance, and 2026 ecosystem developments including Forge, Small 4, and Voxtral TTS.

Learn how to measure AI ROI in drug discovery beyond cost and time savings. Updated for 2026 with 173+ AI clinical programs, Insilico's Phase IIa results, Recursion-Exscientia merger, and new FDA guidance. Key metrics for scientific outcomes, pipeline productivity, and commercial value.

A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, vendor evaluation criteria, and the emerging foundation model licensing trend. Updated April 2026 with EU AI Act compliance deadlines, FDA-EMA joint guidance, and latest pharma AI partnerships.

Updated 2026 guide to AI-assisted SOP drafting in GxP life sciences. Covers FDA CSA final guidance, FDA-EMA GxP-AI Principles, EU AI Act compliance, EMA Annex 22, and validated AI platforms for pharmaceutical quality management.

Explore the ROI of predictive maintenance for lab instruments. Updated for 2026, this guide analyzes ML scheduling cost-benefit factors to reduce downtime and extend equipment life

Learn how AI, LLMs, and agentic AI can build a "Second Brain" for pharma R&D. Updated for 2026 with GraphRAG benchmarks, FDA AI guidance, and enterprise deployment patterns for searchable institutional memory in drug discovery.

Learn how biotech knowledge graphs are built for drug discovery. This guide covers architecture patterns (ETL, ELT, GraphRAG) for integrating compounds, assays, and targets, with 2026 updates on LLM integration and FAIR standards.